These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32982158)

  • 41. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
    Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
    Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 44. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
    Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Hwang HS; Chae JB; Kim JY; Kim DY
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience.
    Hsia NY; Lin CJ; Chen HS; Chang CH; Bair H; Lai CT; Lin JM; Chen WL; Tien PT; Wu WC; Tsai YY
    Front Med (Lausanne); 2021; 8():649979. PubMed ID: 33996856
    [No Abstract]   [Full Text] [Related]  

  • 47. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
    Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series.
    Rishi P; Rishi E; Kuniyal L; Mathur G
    Oman J Ophthalmol; 2012 May; 5(2):79-82. PubMed ID: 22993460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
    Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
    Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema.
    Wang JK; Huang TL; Chang PY
    J Formos Med Assoc; 2020 Nov; 119(11):1619-1625. PubMed ID: 32482606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of markers of outcome in real-world treatment of diabetic macular edema.
    Campos A; Campos EJ; do Carmo A; Caramelo F; Martins J; Sousa JP; Ambrósio AF; Silva R
    Eye Vis (Lond); 2018; 5():27. PubMed ID: 30386806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anatomical and functional responses in eyes with diabetic macular edema treated with "1 + PRN" ranibizumab: one-year outcomes in population of mainland China.
    Lai K; Huang C; Li L; Gong Y; Xu F; Zhong X; Lu L; Jin C
    BMC Ophthalmol; 2020 Jun; 20(1):229. PubMed ID: 32539744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes.
    Neves P; Ornelas M; Matias I; Rodrigues J; Santos M; Dutra-Medeiros M; Martins D
    Int J Ophthalmol; 2021; 14(10):1571-1580. PubMed ID: 34667735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
    Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pro Re Nata Dexamethasone Implant for Treatment-Naive Phakic Eyes with Diabetic Macular Edema: A Prospective Study.
    Bilgic A; Sudhalkar A; Kodjikian L; Vasavada V; Vasavada S; Bhojwani D; Vasavada V; Srivastava S
    Ophthalmol Retina; 2019 Nov; 3(11):929-937. PubMed ID: 31395504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal dexamethasone implants for diabetic macular edema.
    Pareja-Ríos A; Ruiz-de la Fuente-Rodríguez P; Bonaque-González S; López-Gálvez M; Lozano-López V; Romero-Aroca P
    Int J Ophthalmol; 2018; 11(1):77-82. PubMed ID: 29375995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
    Esen E; Sizmaz S; Demircan N
    Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.